172 related articles for article (PubMed ID: 36765490)
21. A benefit and the prospects of IL-6 inhibitors in idiopathic multicentric Castleman's disease.
Koga T; Sumiyoshi R; Kawakami A; Yoshizaki K
Mod Rheumatol; 2019 Mar; 29(2):302-305. PubMed ID: 30285516
[TBL] [Abstract][Full Text] [Related]
22. Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease.
Yu L; Tu M; Cortes J; Xu-Monette ZY; Miranda RN; Zhang J; Orlowski RZ; Neelapu S; Boddu PC; Akosile MA; Uldrick TS; Yarchoan R; Medeiros LJ; Li Y; Fajgenbaum DC; Young KH
Blood; 2017 Mar; 129(12):1658-1668. PubMed ID: 28100459
[TBL] [Abstract][Full Text] [Related]
23. The clinicopathological features and survival of Castleman disease: a multicenter Turkish study.
Yildiz J; Bagci M; Sayin S; Kaya A; Yilmaz F; Ekinci O; Dal MS; Basturk A; Aydogdu I; Albayrak M; Dogan A; Erkurt MA; Korkmaz S; Ulas T; Eser B; Altuntas F
Eur Rev Med Pharmacol Sci; 2022 Feb; 26(4):1131-1137. PubMed ID: 35253168
[TBL] [Abstract][Full Text] [Related]
24. Multicentric Castleman disease of hyaline‑vascular variant with paraneoplastic pemphigus results in abnormal lung function: Report of 3 cases.
Cen J; Zeng W; Pan M; Qiu Y; Zhang J
Exp Ther Med; 2023 Jun; 25(6):269. PubMed ID: 37206548
[TBL] [Abstract][Full Text] [Related]
25. Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease.
Nabel CS; Sameroff S; Shilling D; Alapat D; Ruth JR; Kawano M; Sato Y; Stone K; Spetalen S; Valdivieso F; Feldman MD; Chadburn A; Fosså A; van Rhee F; Lipkin WI; Fajgenbaum DC
PLoS One; 2019; 14(6):e0218660. PubMed ID: 31242229
[TBL] [Abstract][Full Text] [Related]
26. A retrospective study of 34 patients with unicentric and multicentric Castleman's disease: Experience from a single institution.
Jiang JP; Shen XF; Du JF; Guan WX
Oncol Lett; 2018 Feb; 15(2):2407-2412. PubMed ID: 29434951
[TBL] [Abstract][Full Text] [Related]
27. Castleman disease: Experience from a single institution.
Abraham SS; Narayanan G; Thambi SM; Vasudevan JA; Joy Philip DS; Purushothaman PN; Nair SG; Nair R
Med Int (Lond); 2023; 3(6):56. PubMed ID: 37927353
[TBL] [Abstract][Full Text] [Related]
28. Retrospective cohort evaluation of non-HIV Castleman disease from a single academic center in Beijing, China.
Guo M; Nong L; Wang M; Zhang Y; Wang L; Sun Y; Wang Q; Liu H; Ou J; Cen X; Ren H; Dong Y
Ann Hematol; 2024 Jan; 103(1):153-162. PubMed ID: 37749319
[TBL] [Abstract][Full Text] [Related]
29. [Clinical and morphological features of different types of Castleman's disease].
Melikyan AL; Egorova EK; Kovrigina АМ; Subortseva IN; Gilyazitdinova EA; Karagyulyan SR; Silaev MA; Gemdzhian EG; Savchenko VG
Ter Arkh; 2015; 87(7):64-71. PubMed ID: 26390727
[TBL] [Abstract][Full Text] [Related]
30. Human Herpesvirus Type 8-positive Multicentric Castleman Disease.
Melikyan AL; Egorova EK; Julhakyan HL; Kovrigina AL; Savchenko VG
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S159-65. PubMed ID: 27133959
[TBL] [Abstract][Full Text] [Related]
31. Analysis of Clinical Characteristics, Pathological Changes and Changes of Interleukin-6 (IL-6) and C-Reactive Protein (CRP) in Children with Castleman's Disease.
Hu C; Zou Y; Pan J; Yang J; Yang T; Tan T; Li J
Med Sci Monit; 2020 Aug; 26():e924783. PubMed ID: 32873770
[TBL] [Abstract][Full Text] [Related]
32. Recurrence in unicentric castleman's disease postoperatively: a case report and literature review.
Ren N; Ding L; Jia E; Xue J
BMC Surg; 2018 Jan; 18(1):1. PubMed ID: 29301533
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive analysis of 65 patients with Castleman disease in a single center in China.
Wang XQ; Zhong NN; Sun Q; Yan SC; Xu GC; Wang YG; Peng LW; Liu B; Bu LL
Sci Rep; 2022 May; 12(1):8694. PubMed ID: 35610300
[TBL] [Abstract][Full Text] [Related]
34. [Unusual gluteal localization of unicentric Castleman's disease: A case report and review of the literature].
Rizzo S; Camboni A; Van Eeckhout P; Collins P; Somja J
Ann Pathol; 2024 Mar; 44(2):130-136. PubMed ID: 37798152
[TBL] [Abstract][Full Text] [Related]
35. Clinical analysis for 12 patients with thoracic Castleman's disease.
Shen C; Ouyang R; Liu G; Liu T
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Nov; 45(11):1336-1341. PubMed ID: 35753748
[TBL] [Abstract][Full Text] [Related]
36. Imaging of Castleman Disease.
Pitot MA; Tahboub Amawi AD; Alexander LF; LeGout JD; Walkoff L; Navin PJ; Kawashima A; Wood AJ; Dispenzieri A; Venkatesh SK
Radiographics; 2023 Aug; 43(8):e220210. PubMed ID: 37471247
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology of Castleman disease associated with AA amyloidosis: description of 2 new cases and literature review.
Fayand A; Boutboul D; Galicier L; Kahn JE; Buob D; Boffa JJ; Cez A; Oksenhendler E; Grateau G; Ducharme-Bénard S; Georgin-Lavialle S
Amyloid; 2019 Dec; 26(4):197-202. PubMed ID: 31364863
[No Abstract] [Full Text] [Related]
38. Clinicopathological Profile of Castleman's Disease in Indian Population: Experience From a Tertiary Care Center.
Singh A; Purkait S; Mallick S; Ramteke P; Das CK; Gogia A; Sharma MC; Kumar L
Indian J Hematol Blood Transfus; 2020 Apr; 36(2):254-259. PubMed ID: 32425374
[TBL] [Abstract][Full Text] [Related]
39. Multicentric Castleman's disease in India - Does EBV rather than HHV8 play a role?
Bhanvadia V; Shet T; Rao V; Epari S; Gujral S; Jain H; Bagal B; Sengar M
Indian J Pathol Microbiol; 2021; 64(2):302-309. PubMed ID: 33851624
[TBL] [Abstract][Full Text] [Related]
40. Castleman disease and TAFRO syndrome: To improve the diagnostic consciousness is the key.
Zhou QY
World J Clin Cases; 2022 Feb; 10(5):1536-1547. PubMed ID: 35211591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
